The Study of Dried Ginger and Linggan Wuwei Jiangxin Decoction Treatment of Cold Asthma Rats Using GC–MS Based Metabolomics

Abstract

Dried ginger is the monarch drug in Linggan Wuwei Jiangxin (LGWWJX) decoction, which is used to treat cold asthma. The purpose of this study was to investigate and compare the effects of dried ginger and LGWWJX decoction for treatment of cold asthma rats at the metabolomics level using gas chromatography–mass spectrometry (GC–MS). OVA and ice water-induced cold asthma were induced in SD rats. The effects of dried ginger and LGWWJX decoction were evaluated by general morphological observation, hematoxylin and eosin staining, inflammatory cell count, IgE, IL-4, IFN-γ quantitation, and visceral index. GC-MS-based metabolomics was performed and analyzed using multivariate statistical analysis. Biomarker identification, pathway analysis, correlations between identified biomarker, and efficacy indices were performed. The results showed that dried ginger and LGWWJX decoction had obvious effects on cold asthma rats. Thirty-seven metabolites (15 in serum and 22 in urine) associated with cold asthma were identified. These metabolites were mainly carbohydrates, fatty acids and their products, organic acids, and others. Seven pathways were identified by MetaboAnalyst 4.0 metabolic pathway analysis. After intervention with dried ginger and LGWWJX decoction, the majority of altered metabolites and metabolic pathways returned to control levels. LGWWJX decoction regulated more metabolites of carbohydrates and fatty acids, which contribute to energy metabolism and oxidative stress in cold asthma, than dried ginger. We concluded that dried ginger and LGWWJX decoction both were effective for treatment of cold asthma. LGWWJX decoction was more effective than dried ginger for treatment of cold asthma. This study evaluated the effects of dried ginger and LGWWJX decoction on cold asthma at the metabolomics level. It provides a reference for the research on the compatibility of Chinese Medicine.

Yanghe Decoction Suppresses the Experimental Autoimmune Thyroiditis in Rats by Improving NLRP3 Inflammasome and Immune Dysregulation

“…Therefore, 5 g crude drug/kG is close to the human therapeutic dose and 15 g crude drug/kG is the 3-fold of the human therapeutic dose. In this article higher doses of the crude extract were needed to achieve the effect, consistent with previous research demonstrating a dose of 21.6 g/kg Linggan Wuwei Jiangxin decoction was used in a rat study on cold asthma treatment ( Ran et al, 2019 ). Decoction is the most common form with an average of about 12 ingredients in Chinese medicine.…”

Polyphenol‐rich Indian ginger cultivars ameliorate GLUT4 activity in C2C12 cells, inhibit diabetes‐related enzymes and LPS‐induced inflammation: An in vitro study

“…Recently, Ran et al. (2019) reported that dry ginger decoctions could normalize the metabolites levels of glycerol, D‐pinitol in the cold asthma affected rats, but no proof is available for the actual presence of D‐pinitol metabolite in ginger, which was investigated through HPLC analysis. It showed insulin stimulated glucose uptake activity of 1.37 ± 0.32 fold at 25 µM concentration than at the basal level (1.11 ± 0.25 fold) with the same cell line.…”

<p>Urinary Metabolomic Profiling Reveals Biological Pathways and Predictive Signatures Associated with Childhood Asthma</p>

“… 40 Inflammatory factors produced during the development of asthma may simulate the requirement of energy. 41 Interestingly, a prominent change in energy metabolism, eg, the TCA cycle, where most of the body’s energy is generated, 42 has been observed in asthma patients ( Figure 4 ). Notably, succinic acid (an intermediate compound in the TCA cycle) is the third–most enriched metabolite in asthma samples ( Table 2 ).…”